PedAM
Pediatric Disease Annotations & Medicines
| Disease | migraine with aura |
| Phenotype | |migraine with aura |
| Sentences | 316 |
| PubMedID- 23718283 | migraine with aura (ma) involve in addition, but also rarely exclusively, neurologic symptoms (aura) that are caused by waves of cortical spreading depression [12,15-17]. |
| PubMedID- 22888208 | Migraine headache, present in about 12% of the general population, is one of the most frequent causes of disability in the us.3 there is an association between migraine with aura and intracardiac or pulmonary venous to arterial shunting of blood. |
| PubMedID- 21180405 | All headache types are reported to be more prevalent in depressed patients; the strongest association being between depression and migraine with aura[45] elevated one-year prevalence rates for a wide range of psychiatric disorders (anxiety spectrum disorder, depression, bipolar affective disorder) in people with migraine has been reported[46] dysregulation of serotonergic neurotransmission has been postulated to have a key role in the pathogenesis of both major depression and migraine. |
| PubMedID- 24144382 | Single pulse trans-cranial magnetic stimulation of the occipital cortex, was employed by a portable apparatus, to be tested in migraine with aura attacks in a double blind sham controlled study, involving a total of 164 patients and showed a significant effect of verum over sham treatment [131]. |
| PubMedID- 22054256 | They did not differ in the frequency of migraine with aura (em: 37%, fm: 59%; χ2(1) = 1.72, p = .316). |
| PubMedID- 24461875 | The importance of k2p in pain is highlighted by the discovery of a human k+ channelopathy; thus, familial migraine with aura is associated with a dominant-negative mutation in tresk, a subunit strongly expressed in human trigeminal and dorsal root ganglia [67]. |
| PubMedID- 20735819 | Most molecular genetic insight in the pathophysiology of migraine comes from studies of a rare monogenic subtype of migraine with aura, called familial hemiplegic migraine type 1 (fhm-1) [2]. |
| PubMedID- 26382855 | In decreasing order, we found migraine with aura (18.8 %), chronic tension-type headache (15.9 %), and episodic tension-type headache (8.4 %). |
| PubMedID- 22466285 | In addition, ichd-ii was also applied to divide the patients into subgroups, and the subgroups included migraine with aura (ma) and migraine without aura (moa) or episodic migraine (em) and chronic migraine (cm) [17]. |
| PubMedID- 21493642 | Ma = migraine with aura. |
| PubMedID- 23519073 | At twelve years he developed a migraine with aura. |
| PubMedID- 26170679 | The widely accepted theory for migraine with aura suggests that cortical spreading depression, a wave of neuronal hyperactivity followed by an area of cortical depression, accounts for the aura22,23 and that the headache depends on activation of the trigeminovascular pain pathway.24,25 in cm, atypical pain processing, central and peripheral sensitization, cortical hyperexcitability, and neurogenic inflammation all have a role to play.26 the pain of migraine suggests an important role of the nociceptive activation of the trigeminovascular pathway.27 in migraine sufferers, pain-induced functional activation of pain-inhibiting brainstem regions and the functional connectivity of brainstem pain modulatory regions are atypical.26,28 this atypical pain modulation appears to play a role in transformation of em to cm. |
| PubMedID- 22110941 | Other dopamine receptor and transporter gene snps were not linked to migraine in spanish samples [64, 65] but dopamine transporter and dopamine beta-hydroxylase gene snps did show an association to migraine with aura in other european samples [66]. |
| PubMedID- 25904144 | *p < 0.05, **p < 0.01, ***p < 0.001. mwa = migraine with aura, mwoa = migraine without aura. |
| PubMedID- 22623072 | Nevertheless, cases of de novo migraine or exacerbated migraine with aura in prior migraine sufferers have been described following percutaneous closure of some asd [3–6], something that does not appear to hold true in the case of similar treatment procedures for pfo. |
| PubMedID- 21892339 | At this time, contraindications to use of e2v/dng are the same as those for ethinyl estradiol-containing combined oral contraceptive pills, including pregnancy, uncontrolled hypertension, migraine with aura, acquired or inherited predisposition to arterial or venous thrombosis, coronary artery disease, breast cancer, heavy smoking, complicated valvular heart disease, severe hepatic disease including liver cancer, and history of current stroke or thromboembolism. |